TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: LSU Will Be Headquarters For National Pancreatic Project; Budget For First Year Will Be $1 Million December 6, 1974
TCL Archive Hammer’s “March Of dollars” Starts Collecting Money; Four Year Campaign Kicks Off Oct 12 September 2, 1988
